Business Standard
Wednesday, May 30, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

Merieux may divest stake in Shantha Bio
BS Reporter / Chennai/ Hyderabad Apr 27, 2009, 00:48 IST

French healthcare company Merieux Alliance, which holds a 78.85 per cent stake in Hyderabad-based vaccine manufacturer and biopharmaceutical firm Shantha Biotechnics, might dilute some of its stake, according to Shantha founder and managing director KI Vara Prasad Reddy.

The company has, however, assured to remain a majority stakeholder and hold at least 51 per cent to ensure that the new partner did not bring a drastic change in the line of operations, said Reddy. The dilution of stake is to bring in new technology, new products or enter new markets or a combination of these. Reddy holds a 14.1 per cent stake in Shantha.

 
The French company picked up a majority stake (60 per cent) in Shantha Biotechnics in November 2006 from Oman-based financial firms to strengthen its India presence.

On reports that Shantha was a target for an acquisition, he said the company was attractive with proven capabilities in vaccine development and market penetration and, therefore, many companies including one from Hyderabad were eyeing to acquire it. "I declined to sell my stake in the company so some of them are approaching Merieux for dilution of its stake,'' Reddy said, adding the company, which is not seeing any drastic upward or downward surges, had been getting acquisition proposals from various companies since the late 90s.

“Merieux is still taking my opinion on company issues. But I do not know for how long they would do so,” he said.

Interacting with the media here on Friday on the sidelines of announcing the launch of Shanchol, an oral cholera vaccine, he said the company would continue to work on low-cost vaccines. Shanchol would be priced at about Rs 300 per dose of 1.5 ml and two doses were needed to give protection against cholera for about four years. The commercial launch would be in June or July.

The company has invested about Rs 5 crore over three years in developing Shanchol in collaboration with the International Vaccine Institute, Seoul. It received funding from the Bill and Melinda Gates Foundation for the project.

Currently, the Hyderabad facility has a capacity to manufacture 5 million doses, which would be ramped up to 25 million doses in about six months.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end lower ahead of May F&O expiry
- Rupee closes at new low of 56.24
- Wall Street opens 1% lower on Europe
- Shashi Ruia steps down from board of Essar Ports
- Sebi allows firms listed on RSEs to migrate to main bourses
  Read Business news in 
- India's no. 1 Property Site. Click here to know more
- "Discover The Power of One"
- Journey on, We are by Your Side. Click here to know more
- Help a Child Achieve her. Click to know more
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- The Best Seller is Also the No. 1 in Mileage. Click here
- Watch The Film Here. Click here to know more..
- Leader in Passenger Car & Automobile Tyres. Click here
- Learn How One City is Running on FOOD SCRAPS.
- 1 billion in saving for Unilever without any tangles.
- A Brand New Server at a Price That Fits Your Budget. Click here
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- 36 Lakhs can get you a pool of Luxuries. Click here
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
- 2 Lac Apartments, 1 Lac House / Plots. Click here
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Striking Air India pilots have no rights to be trained: HC
- SBI to rework structure in circles
- KBC 6 gets record registrations
- UPDATE: NDA calls for Bharat Bandh on May 31
- Foreign investor norms eased to accelerate capital inflows
 
 More  
Tax Shastra
  Now available at Special price
  Rs. 360/- Only

  Buy Now
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us